IBEX (NASDAQ:IBEX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.
Other equities research analysts also recently issued research reports about the stock. Robert W. Baird upped their price target on shares of IBEX from $35.00 to $40.00 and gave the company a “neutral” rating in a research note on Friday. Weiss Ratings restated a “hold (c+)” rating on shares of IBEX in a report on Friday, July 31st. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, IBEX currently has a consensus rating of “Hold” and an average target price of $40.00.
View Our Latest Research Report on IBEX
IBEX Price Performance
IBEX (NASDAQ:IBEX – Get Free Report) last posted its earnings results on Thursday, September 10th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.01. IBEX had a return on equity of 28.96% and a net margin of 7.19%.The firm had revenue of $164.27 million during the quarter, compared to the consensus estimate of $160.02 million.
Insider Activity
In related news, COO David Afdahl sold 17,500 shares of IBEX stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $37.09, for a total transaction of $649,075.00. Following the completion of the transaction, the chief operating officer directly owned 140,006 shares of the company’s stock, valued at approximately $5,192,822.54. The trade was a 11.11% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 3.40% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Advisory Services Network LLC bought a new stake in shares of IBEX during the 3rd quarter worth approximately $46,000. Empowered Funds LLC purchased a new stake in shares of IBEX during the fourth quarter valued at $84,000. Clearstead Advisors LLC boosted its stake in shares of IBEX by 159.1% during the fourth quarter. Clearstead Advisors LLC now owns 2,635 shares of the company’s stock valued at $101,000 after purchasing an additional 1,618 shares during the period. Amundi bought a new position in shares of IBEX in the first quarter worth about $74,000. Finally, California State Teachers Retirement System grew its holdings in shares of IBEX by 667.7% in the second quarter. California State Teachers Retirement System now owns 4,161 shares of the company’s stock worth $137,000 after purchasing an additional 3,619 shares during the last quarter. Institutional investors own 81.24% of the company’s stock.
Trending Headlines about IBEX
Here are the key news stories impacting IBEX this week:
- Positive Sentiment: Above-consensus fiscal 2027 outlook: IBEX forecast fiscal 2027 revenue of $700 million to $715 million, well above the $678.5 million analyst consensus. First-quarter fiscal 2027 revenue guidance of $168 million to $170 million also exceeded the $161.4 million consensus. The outlook reflects continued growth in AI-powered customer-experience services, including the Sierra AI partnership. IBEX fiscal 2026 results and fiscal 2027 guidance
- Positive Sentiment: Quarterly earnings beat estimates: IBEX reported adjusted earnings of $0.85 per share, topping the $0.84 consensus, while revenue reached $164.27 million versus expectations of $160.02 million. A 7.53% net margin and 31.50% return on equity further support the company’s strong operating performance. IBEX quarterly earnings report
- Positive Sentiment: Price target raised: Robert W. Baird increased its IBEX target from $35 to $40. However, the firm maintained a neutral rating, suggesting limited additional upside at recent trading levels.
- Neutral Sentiment: Short-interest data offers little signal: Reported short interest was zero shares, meaning there is no measurable short-covering catalyst or significant reported bearish positioning.
- Negative Sentiment: COO sold shares: Chief Operating Officer David Afdahl sold 17,500 shares worth approximately $649,075, reducing his direct ownership by 11.11%. The transaction occurred under a pre-arranged Rule 10b5-1 plan, which makes it a less concerning signal than a discretionary insider sale. IBEX insider trading filing
About IBEX
IBEX Limited (NASDAQ: IBEX) is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.
The company’s services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.
IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.
Featured Articles
- Five stocks we like better than IBEX
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
